initial public offerings (IPOs) trading on American exchanges

Thursday, October 10, 2019

BioNTech (BNTX) began trading on the Nasdaq on Thur 10 Oct 19

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases.

  • Sector: Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 1,179
  • Founded in 2008
  • HQ in Mainz, Germany
BioNTech priced 10 mln share IPO at $15.00, the low-end of the reduced $15.00-$16.00 range

No comments:

Post a Comment